Alaunos Therapeutics, INC. (TCRT) SEC Filings — 2024

Filings

• Alaunos Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Alaunos Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
• Alaunos Therapeutics Terminates Material Agreement — 8-K · Oct 10, 2024
• Alaunos Therapeutics Files 10-Q, Details R&D and G&A Expenses — 10-Q · Aug 14, 2024
• Alaunos Therapeutics Files 8-K/A Amendment — 8-K/A · Jul 17, 2024
• NuScale Power to Acquire Alaunos Therapeutics — 8-K · Jul 16, 2024
• Alaunos Therapeutics to be acquired by 3D Medicines for $100M — 8-K · Jun 21, 2024
• Alaunos Therapeutics Files 8-K: Corporate Changes and Shareholder Votes — 8-K · Jun 12, 2024
• Alaunos Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
• Alaunos Therapeutics Announces 2024 Annual Meeting and Proxy Statement — DEF 14A · Apr 26, 2024
• Alaunos Therapeutics Files 2023 Annual Report on Form 10-K — 10-K · Apr 1, 2024
• Alaunos Therapeutics Reports Executive Changes and Compensation Updates — 8-K · Feb 22, 2024
• Alaunos Therapeutics Files 8-K on Feb 16 Event — 8-K · Feb 20, 2024
• Alaunos Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Alaunos Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Alaunos Therapeutics Amends Charter Documents — 8-K · Feb 1, 2024
• Alaunos Therapeutics Files 8-K, Confirms Nasdaq Listing — 8-K · Jan 29, 2024
• Alaunos Therapeutics Files Standard 8-K; No Major Changes Reported — 8-K · Jan 22, 2024
• Alaunos Therapeutics Reports Executive Changes & Compensation on Dec 29 — 8-K · Jan 2, 2024